|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Accounts receivable, net | ||||
| Prepaid expenses and other current assets | ||||
| Total current assets | ||||
| Property and equipment, net | ||||
| Right-of-use assets, net | ||||
| Other non-current assets | ||||
| Total assets | ||||
| Current liabilities: | ||||
| Accounts payable and accrued expenses | ||||
| Note payable - stockholder | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Deferred revenue | ||||
| Insurance premium financing payable | ||||
| Notes payable current, net | ||||
| Operating lease liability, current | ||||
| Warrant liability | ||||
| Total current liabilities | ||||
| Operating lease liability, non-current | ||||
| Total liabilities | ||||
| Redeemable convertible preferred stock; 21,987,039 shares authorized; 0 shares issued and outstanding as of June 30, 2026 and 18,994,952 shares issued and outstanding as of September 30, 2025, Liquidation value of $91,397,911 as of September 30, 2025 | ||||
| Stockholders’ equity (deficit): | ||||
| Common stock, par value $0.0001; 500,000,000 shares authorized; 48,312,482 and 13,150,921 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Stockholders’ equity (deficit) | ||||
| Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit |
Loading...